Latest filings (excl ownership)
10-Q
2024 Q1
Quarterly report
10 May 24
8-K
ProKidney Reports Business Updates and First Quarter 2024 Financial Results
10 May 24
ARS
2023 FY
Annual report to shareholders
26 Apr 24
DEF 14A
Definitive proxy
26 Apr 24
8-K
ProKidney Announces Key Leadership Appointments Strengthening Clinical and Technical Operations
25 Mar 24
S-8
Registration of securities for employees
22 Mar 24
8-K
ProKidney Reports Full Year 2023 Financial Results and Recent Corporate Highlights
21 Mar 24
10-K
2023 FY
Annual report
21 Mar 24
8-K/A
Departure of Directors or Certain Officers
18 Mar 24
8-K/A
Departure of Directors or Certain Officers
18 Mar 24
8-K
Departure of Directors or Certain Officers
12 Feb 24
8-K
Regulation FD Disclosure
26 Jan 24
8-K
Entry into a Material Definitive Agreement
19 Jan 24
424B5
Prospectus supplement for primary offering
19 Jan 24
8-K/A
Departure of Directors or Certain Officers
5 Dec 23
EFFECT
Notice of effectiveness
1 Dec 23
8-K
Departure of Directors or Certain Officers
30 Nov 23
CORRESP
Correspondence with SEC
28 Nov 23
UPLOAD
Letter from SEC
27 Nov 23
S-3
Shelf registration
22 Nov 23
8-K
Regulation FD Disclosure
20 Nov 23
8-K
ProKidney Reports Third Quarter Financial Results
14 Nov 23
10-Q
2023 Q3
Quarterly report
14 Nov 23
8-K
Departure of Directors or Certain Officers
13 Nov 23
8-K
Regulation FD Disclosure
11 Sep 23
424B3
Prospectus supplement
22 Aug 23
EFFECT
Notice of effectiveness
22 Aug 23
POS AM
Prospectus update (post-effective amendment)
18 Aug 23
424B3
Prospectus supplement
11 Aug 23
8-K
ProKidney Reports Second Quarter Financial Results and Recent Corporate Highlights
10 Aug 23
10-Q
2023 Q2
Quarterly report
10 Aug 23
424B3
Prospectus supplement
25 Jul 23
8-K
ProKidney Announces Closing of Purchase of Manufacturing Facility in Greensboro, NC
18 Jul 23
424B3
Prospectus supplement
6 Jul 23
8-K
Submission of Matters to a Vote of Security Holders
30 Jun 23
424B3
Prospectus supplement
23 Jun 23
8-K
ProKidney Announces Purchase of Manufacturing Facility in Greensboro, NC
16 Jun 23
ARS
2022 FY
Annual report to shareholders
26 May 23
DEF 14A
Definitive proxy
26 May 23
424B3
Prospectus supplement
26 May 23
Latest ownership filings
4
Darin J. Weber
22 May 24
144
Notice of proposed sale of securities
20 May 24
4
Change in insider ownership
16 May 24
4
Darin J. Weber
23 Apr 24
144
Notice of proposed sale of securities
18 Apr 24
4
Darin J. Weber
17 Apr 24
4
Darin J. Weber
16 Apr 24
144
Notice of proposed sale of securities
16 Apr 24
144
Notice of proposed sale of securities
12 Apr 24
4
Ulrich Peter Alfred Ernst
2 Apr 24
3
Ulrich Peter Alfred Ernst
2 Apr 24
144
Notice of proposed sale of securities
1 Apr 24
4
James Coulston
5 Mar 24
4
Todd C Girolamo
5 Mar 24
4
Darin J. Weber
5 Mar 24
SC 13G/A
SUVRETTA CAPITAL MANAGEMENT, LLC
13 Feb 24
SC 13G/A
MORGAN STANLEY
9 Feb 24
4
Todd C Girolamo
6 Feb 24
4
Darin J. Weber
6 Feb 24
4
Pablo G. Legorreta
6 Feb 24
SC 13D/A
Tolerantia, LLC
6 Feb 24
4
Bruce Culleton
5 Dec 23
4
Chamath Palihapitiya
21 Nov 23
SC 13D/A
Palihapitiya Chamath
20 Nov 23
4
Chamath Palihapitiya
17 Nov 23
4
Chamath Palihapitiya
14 Nov 23
4
Chamath Palihapitiya
8 Nov 23
4
Chamath Palihapitiya
3 Nov 23
SC 13D/A
Palihapitiya Chamath
3 Nov 23
SC 13D
Tolerantia, LLC
2 Nov 23
4
Pablo G. Legorreta
1 Nov 23
4
Chamath Palihapitiya
31 Oct 23
SC 13D/A
Palihapitiya Chamath
26 Oct 23
4
Chamath Palihapitiya
26 Oct 23
4
Chamath Palihapitiya
23 Oct 23
SC 13D/A
Palihapitiya Chamath
18 Oct 23
4
Chamath Palihapitiya
18 Oct 23
4
Chamath Palihapitiya
13 Oct 23
4
Chamath Palihapitiya
10 Oct 23
SC 13D/A
Palihapitiya Chamath
21 Sep 23